Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer.

Hiroki Goya,Hiroshi Kuraishi,Shigeru Koyama,Takashi Ichiyama,Fumiaki Yoshiike,Kazuya Hirai,Toshihiko Agatsuma,Kazunari Tateishi,Shintaro Kanda,Hiroshi Yamamoto,Keishi Kubo,Tomonobu Koizumi

Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer.

2012

Hiroki Goya
Hiroshi Kuraishi
Shigeru Koyama
Takashi Ichiyama
Fumiaki Yoshiike
Kazuya Hirai
Toshihiko Agatsuma
Kazunari Tateishi
Shintaro Kanda
Hiroshi Yamamoto
Keishi Kubo
Tomonobu Koizumi

Purpose This phase I/II study was designed to evaluate a combination of irinotecan and S-1 a new regimen for salvage chemotherapy in patients with advanced or metastatic non-small cell lung cancer (NSCLC).

Keywords:

Regimen
Cancer research
Irinotecan
Pharmacology
Oncology
Lung cancer
Medicine
Internal medicine
Chemotherapy
salvage treatment
non small cell
phase i ii
previously treated

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations